Treatment of the overactive bladder with tolterodine, a new muscarinic receptor antagonist

被引：12

作者：

Messelink, EJ ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Urol, NL-1105 AZ Amsterdam, Netherlands

来源：

BJU INTERNATIONAL | 1999年 / 83卷

关键词：

tolterodine; oxybutynin; randomized controlled trials; bladder symptoms; efficacy; adverse events;

D O I：

10.1046/j.1464-410X.83.s2.10.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：48 / 52

页数：5

共 10 条

[1]

Abrams P, 1998, BRIT J UROL, V81, P801

[2] STANDARDIZATION OF TERMINOLOGY OF LOWER URINARY-TRACT FUNCTION [J].

ABRAMS, P ;

BLAIVAS, JG ;

STANTON, SL ;

ANDERSEN, JT .

NEUROUROLOGY AND URODYNAMICS, 1988, 7 (05) :403-427

[3] Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis [J].

Appell, RA .

UROLOGY, 1997, 50 (6A) :90-96

[4]

Brynne N, 1997, INT J CLIN PHARM TH, V35, P287

[5] Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: Urodynamic evaluation [J].

Jonas, U ;

Hofner, K ;

Madersbacher, H ;

Holmdahl, TH ;

Bucher, A ;

Frick, J ;

Heidler, H ;

Pfluger, H ;

Primus, G ;

Schmidbauer, C ;

Zechner, O ;

Alloussi, S ;

Anthuber, C ;

Blau, U ;

Dimpfl, T ;

Flach, K ;

Frohlich, G ;

Frohneberg, D ;

Geier, G ;

Hannappel, J ;

Hartung, R ;

Haubensak, K ;

Herrlinger, A ;

Hiller, O ;

Hofstetter, A ;

Horsch, R ;

Junemann, KP ;

Kindt, J ;

Koszegi, F ;

Lahm, AW ;

Lammle, G ;

Laval, KU ;

Melchior, H ;

Methfessel, HD ;

Rudolph, R ;

Terhorst, B ;

Vilmar, W ;

Weidenfeld, M ;

Frykman, H ;

Granberg, G ;

Haendler, L ;

Larsson, C .

WORLD JOURNAL OF UROLOGY, 1997, 15 (02) :144-151

[6] A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance [J].

Kelleher, CJ ;

Cardozo, LD ;

Khullar, V ;

Salvatore, S .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (09) :988-993

[7] Tolterodine - A new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical data [J].

Nilvebrant, L ;

Hallen, B ;

Larsson, G .

LIFE SCIENCES, 1997, 60 (13-14) :1129-1136

[8]

NILVEBRANT L, 1997, EUR J PHARMACOL, V327, P196

[9]

Rentzhog L, 1998, BRIT J UROL, V81, P42

[10] Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivity [J].

Stahl, MMS ;

Ekstrom, B ;

Sparf, B ;

Mattiasson, A ;

Andersson, KE .

NEUROUROLOGY AND URODYNAMICS, 1995, 14 (06) :647-655

← 1 →